- Telehealth visits
Sharon Orbach Wietstock, MD, MS
Neurology • Pediatric NeurologyDirector, Neurotrauma Program- Telehealth visits
Sharon Orbach Wietstock, MD, MS
Neurology • Pediatric NeurologyDirector, Neurotrauma Program- Telehealth visits
On this page
About me
Dr. Sharon Orbach Wietstock is a pediatric neurologist, specializing in the care of patients with neurologic illness in the hospital. As a neurohospitalist, she provides critical care to hospitalized infants, children and young adults with neurological conditions. She has expertise in diagnosing, stabilizing and managing nervous system abnormalities, as well as in preventing additional complications. She collaborates with other pediatricians and specialists to minimize brain, spinal and nerve injuries, with the goal of improving quality of life for some of the hospital's most vulnerable patients. She is director of the Neurotrauma Program.
Wietstock earned a master's degree in neuroscience at Magdalen College at the University of Oxford and her medical degree at UCSF. She completed a residency in pediatrics and a fellowship in child neurology at UCSF. She also completed advanced training in clinical research at UCSF.
Wietstock belongs to the American Academy of Neurology and Child Neurology Society.
Education & training
Board certification
- Neurology w/ Special Qualification in Child Neurology - General, American Board of Psychiatry and Neurology
Residency
- Pediatrics, UCSF School of Medicine -GME
Degree
- MD, UCSF School of Medicine
Academic Title
- Health Sciences Clinical Professor
My expertise
Specialties
Locations
My research
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.